These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20308309)

  • 1. Immunotherapy for glioblastoma: a long and winding road.
    Weller M
    Neuro Oncol; 2010 Apr; 12(4):319. PubMed ID: 20308309
    [No Abstract]   [Full Text] [Related]  

  • 2. How immunotherapies are targeting the glioblastoma immune environment.
    Felthun J; Reddy R; McDonald KL
    J Clin Neurosci; 2018 Jan; 47():20-27. PubMed ID: 29042147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties.
    Rodrigues JC; Gonzalez GC; Zhang L; Ibrahim G; Kelly JJ; Gustafson MP; Lin Y; Dietz AB; Forsyth PA; Yong VW; Parney IF
    Neuro Oncol; 2010 Apr; 12(4):351-65. PubMed ID: 20308313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell therapy targets glioblastoma.
    Cancer Discov; 2015 May; 5(5):458. PubMed ID: 25783861
    [No Abstract]   [Full Text] [Related]  

  • 5. Achieving efficacious immunotherapy for patients with glioblastoma.
    Young JS
    Expert Rev Anticancer Ther; 2020 Nov; 20(11):909-911. PubMed ID: 32852237
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunotherapy in glioblastoma: emerging options in precision medicine.
    Hodges TR; Ferguson SD; Heimberger AB
    CNS Oncol; 2016 Jul; 5(3):175-86. PubMed ID: 27225028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solving the riddle of glioblastoma: The hope for immunotherapy.
    Bashir R; Mohile NA
    Neurology; 2016 Jun; 86(24):2220-1. PubMed ID: 27225224
    [No Abstract]   [Full Text] [Related]  

  • 8. Current State of Immune-Based Therapies for Glioblastoma.
    Lim M; Weller M; Chiocca EA
    Am Soc Clin Oncol Educ Book; 2016; 35():e132-9. PubMed ID: 27249715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy and radiation in glioblastoma.
    Sahebjam S; Sharabi A; Lim M; Kesarwani P; Chinnaiyan P
    J Neurooncol; 2017 Sep; 134(3):531-539. PubMed ID: 28567588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioblastoma antigen discovery--foundations for immunotherapy.
    Azad TD; Razavi SM; Jin B; Lee K; Li G
    J Neurooncol; 2015 Jul; 123(3):347-58. PubMed ID: 26045361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cell immunotherapy for glioblastoma.
    Polyzoidis S; Ashkan K
    Expert Rev Anticancer Ther; 2014 Jul; 14(7):761-3. PubMed ID: 24850137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining immunotherapy with radiation for the treatment of glioblastoma.
    Chow KK; Hara W; Lim M; Li G
    J Neurooncol; 2015 Jul; 123(3):459-64. PubMed ID: 25877468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The intersection between genetic engineering and immunotherapy: taking a BiTE out of glioblastoma.
    Njoku I; Boockvar JA
    Neurosurgery; 2013 Jun; 72(6):N16-7. PubMed ID: 23685511
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytomegalovirus-targeted immunotherapy and glioblastoma: hype or hope?
    Ferguson SD; Srinivasan VM; Ghali MG; Heimberger AB
    Immunotherapy; 2016; 8(4):413-23. PubMed ID: 26973123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Armed hunter killers: discerning the role of adoptive T-cell transfer for glioblastoma.
    Samaha H; El Naggar S; Ahmed N
    Immunotherapy; 2015; 7(5):481-5. PubMed ID: 26065474
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of human autologous cytotoxic T lymphocytes against minced tissues of glioblastoma multiforme.
    Tsurushima H; Liu SQ; Tsuboi K; Yoshii Y; Nose T; Ohno T
    J Neurosurg; 1996 Feb; 84(2):258-63. PubMed ID: 8592229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in immunotherapy for the treatment of glioblastoma.
    Tivnan A; Heilinger T; Lavelle EC; Prehn JH
    J Neurooncol; 2017 Jan; 131(1):1-9. PubMed ID: 27743144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioblastoma Immune Landscape and the Potential of New Immunotherapies.
    Daubon T; Hemadou A; Romero Garmendia I; Saleh M
    Front Immunol; 2020; 11():585616. PubMed ID: 33154756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological characterization of glioblastoma cells for immunotherapy.
    Jung TY; Choi YD; Kim YH; Lee JJ; Kim HS; Kim JS; Kim SK; Jung S; Cho D
    Anticancer Res; 2013 Jun; 33(6):2525-33. PubMed ID: 23749904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current challenges in designing GBM trials for immunotherapy.
    Weathers SP; Gilbert MR
    J Neurooncol; 2015 Jul; 123(3):331-7. PubMed ID: 25577401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.